These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7657323)

  • 21. Prevention of peritoneal carcinomatosis in mice with combination hyperthermal intraperitoneal chemotherapy and IL-2.
    Bevanda M; Orsolic N; Basic I; Vukojevic K; Benkovic V; Horvat Knezevic A; Lisicic D; Dikic D; Kujundzic M
    Int J Hyperthermia; 2009 Mar; 25(2):132-40. PubMed ID: 19337913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer].
    Deng C; Huang R; Lian L
    Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):159-62. PubMed ID: 8758790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of bleomycin on the cell cycle of Ehrlich ascites carcinoma.
    Nagatsu M; Richart RM; Lambert A
    Cancer Res; 1972 Sep; 32(9):1966-70. PubMed ID: 4118376
    [No Abstract]   [Full Text] [Related]  

  • 24. Increased antitumor efficacy by the combined administration of swainsonine and cisplatin in vivo.
    Santos FM; Latorre AO; Hueza IM; Sanches DS; Lippi LL; Gardner DR; Spinosa HS
    Phytomedicine; 2011 Sep; 18(12):1096-101. PubMed ID: 21763115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of intraperitoneal implanted human ovarian carcinoma of nude mice by angiostatin gene and chemotherapy in vivo].
    Sun P; Kong BH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Feb; 30(1):91-4. PubMed ID: 18361061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous hyperthermic peritoneal perfusion (CHPP) for malignant ascites and irresectable intra-abdominal cancer.
    Ben-Ari G; Scott D; Zippel D; Sareli M; Koller M; Papa M
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():436-9. PubMed ID: 10895192
    [No Abstract]   [Full Text] [Related]  

  • 27. Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis.
    Detroz B; Laurent S; Honoré P; Blaffart F; Limet R; Meurisse M
    Acta Chir Belg; 2004 Aug; 104(4):377-83. PubMed ID: 15469146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ascitic and solid Ehrlich tumor inhibition by Chenopodium ambrosioides L. treatment.
    Nascimento FR; Cruz GV; Pereira PV; Maciel MC; Silva LA; Azevedo AP; Barroqueiro ES; Guerra RN
    Life Sci; 2006 Apr; 78(22):2650-3. PubMed ID: 16307762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antitumor effect of intraperitoneal treatment with rhTNF-alpha muteins on Ehrlich ascites tumor growth.
    Terlikowski S; Nowak HF
    Cancer Biother Radiopharm; 2000 Feb; 15(1):39-46. PubMed ID: 10740651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers].
    Kurihara N; Kumai K; Kubota T; Furukawa T; Yamamoto T; Shimada A; Shibata S; Saikawa Y; Ogawa S; Murayama Y
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1645-8. PubMed ID: 8373238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of disappearance of peritoneal dissemination in gastric cancer induced by continuous hyperthermic peritoneal perfusion with cisplatin and mitomycin C].
    Fujimura T; Yonemura Y; Urade M; Sugiyama K; Hasegawa H; Hashimoto T; Miyata R; Matsuda Y; Katayama K; Yamaguchi A
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2331-4. PubMed ID: 3136703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Proliferation kinetics of Ehrlich ascites tumors during cisplatin administration].
    Krug H; Taubert G; Lenschow S
    Acta Histochem Suppl; 1990; 39():61-5. PubMed ID: 2080294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Docetaxel combined with intraperitoneal hyperthermic perfusion chemotherapy and hyperthermia in the treatment of advanced ovarian cancer.
    Zhang T; Pan Q; Xiao S; Li L; Xue M
    Oncol Lett; 2016 May; 11(5):3287-3292. PubMed ID: 27123104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin.
    Loggie BW; Fleming RA; McQuellon RP; Russell GB; Geisinger KR
    Am Surg; 2000 Jun; 66(6):561-8. PubMed ID: 10888132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
    Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
    Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotoxicity and cytotoxicity of cisplatin treatment combined with anaesthetics on EAT cells in vivo.
    Brozovic G; Orsolic N; Knezevic F; Horvat Knezevic A; Benkovic V; Sakic K; Hrgovic Z; Bendelja K; Fassbender WJ
    Onkologie; 2009 Jun; 32(6):337-43. PubMed ID: 19521121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
    Yamamoto N; Naraparaju VR
    Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular endothelial growth factor immunoneutralization in combination with cisplatin reduces EAC tumor growth.
    Ghosh S; Maity P
    Int Immunopharmacol; 2006 Oct; 6(10):1550-9. PubMed ID: 16919827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful palliation of malignant ascites from peritoneal mesothelioma by laparoscopic intraperitoneal hyperthermic chemotherapy.
    Patriti A; Cavazzoni E; Graziosi L; Pisciaroli A; Luzi D; Gullà N; Donini A
    Surg Laparosc Endosc Percutan Tech; 2008 Aug; 18(4):426-8. PubMed ID: 18716551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, and role of laparoscopy in diagnosis, staging, and treatment.
    Valle M; Federici O; Garofalo A
    Surg Oncol Clin N Am; 2012 Oct; 21(4):515-31. PubMed ID: 23021713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.